INR 244.35
(-5.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Cash Flow | -999.21 Million | -5.35 Million | -1.63 Million | -1.64 Million |
Net Income | 13.87 Million | 10.08 Million | 2.24 Million | 661.48 Thousand |
Depreciation & Amortization | 99 Thousand | 113 Thousand | - | 85.75 Thousand |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -1.01 Billion | -24.23 Million | -3.88 Million | -2.89 Million |
Other non-cash items | - | 8.69 Million | 3.88 Million | 3.56 Million |
Investing Cash Flow | - | -3.71 Million | - | -38.13 Thousand |
Investments in PPE | - | -3.71 Million | - | -38.13 Thousand |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | - | - |
Financing Cash Flow | 68.2 Million | 9.92 Million | 1.71 Million | 1.04 Million |
Debt repayment | - | -9.92 Million | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 70.25 Million | - | - | - |
Other Financing Activities | -2.05 Million | 9.92 Million | 1.71 Million | 1.04 Million |
Accounts receivables | -18.3 Million | -24.23 Million | -4.91 Million | -4.14 Million |
Accounts payables | -970.72 Million | 8.78 Million | 1.03 Million | 1.24 Million |
Inventory | -24.16 Million | - | - | - |
Other working capital | - | - | - | - |
Cash at beginning of period | 1.55 Million | 725 Thousand | 646.28 Thousand | 1.29 Million |
Cash at end of period | 52.46 Million | 1.55 Million | 725 Thousand | 646.28 Thousand |
Capital Expenditure | - | -3.71 Million | - | -38.13 Thousand |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 50.9 Million | 833 Thousand | 78.71 Thousand | -646.22 Thousand |
Free Cash Flow | -999.21 Million | -9.07 Million | -1.63 Million | -1.68 Million |
Breakdown | 2022 FY | 2022 Q4 | 2021 FY | 2020 FY |
---|---|---|---|---|
Operating Cash Flow | - | - | - | - |
Net Income | 10.08 Million | 7.2 Million | 2.24 Million | 661.48 Thousand |
Depreciation & Amortization | 113 Thousand | - | - | 85.75 Thousand |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -15.45 Million | - | -3.88 Million | -2.89 Million |
Other non-cash items | 15.58 Million | -7.2 Million | 3.88 Million | 3.56 Million |
Investing Cash Flow | -3.71 Million | - | - | -38.13 Thousand |
Investments in PPE | -3.71 Million | - | - | -38.13 Thousand |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | - | - | - | - |
Financing Cash Flow | 9.92 Million | - | 1.71 Million | 1.04 Million |
Debt repayment | -9.92 Million | - | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | - | - | - |
Other Financing Activities | - | - | 1.71 Million | 1.04 Million |
Accounts receivables | -24.23 Million | - | -4.91 Million | -4.14 Million |
Accounts payables | 8.78 Million | - | 1.03 Million | 1.24 Million |
Inventory | - | - | - | - |
Other working capital | - | - | - | - |
Cash at beginning of period | 725 Thousand | - | 646.28 Thousand | 1.29 Million |
Cash at end of period | 1.55 Million | - | 725 Thousand | 646.28 Thousand |
Capital Expenditure | -3.71 Million | - | - | -38.13 Thousand |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 833 Thousand | - | 78.71 Thousand | -646.22 Thousand |
Free Cash Flow | -9.07 Million | - | -1.63 Million | -1.68 Million |
3678
4290
DMED
0585
BYDIF
5483